FDA Drugs (New Approvals & NDA)Original article
Nonprescription Drug Product with an Additional Condition for Nonprescription Use
RegulatoryFDA-2021Neutral
AI Analysis
Summary
The FDA announced the availability of a proposed rule establishing requirements for nonprescription drug products with additional conditions for nonprescription use (Docket No. FDA-2021-N-0862).
Outcome Details
Proposed rule for establishing requirements for nonprescription drug products with additional conditions for nonprescription use
Importance:2/10
Sentiment:
0.00
FDARegulatoryNonprescriptionProposed RuleOTC
Read the original article
Published by FDA Drugs (New Approvals & NDA) on August 13, 2026 2:01 PM